Cite
HARVARD Citation
da Costa, M. et al. (2022). Reduction in the cerebrospinal fluid protein level after bevacizumab treatment in patients with optic pathway low‐grade gliomas. Pediatric blood & cancer. 69 (5), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
da Costa, M. et al. (2022). Reduction in the cerebrospinal fluid protein level after bevacizumab treatment in patients with optic pathway low‐grade gliomas. Pediatric blood & cancer. 69 (5), p. n/a. [Online].